×
About 9,550 results

ALLMedicine™ Leukemias Center

Research & Reviews  4,523 results

Patterns of surveillance for late effects of BCR-ABL tyrosine kinase inhibitors in surv...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082962
BMC Cancer; Smith SM, Sabnis HS et. al.

Apr 30th, 2021 - Targeted anticancer therapies such as BCR-ABL tyrosine kinase inhibitors (TKIs) have improved outcomes for chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph + ALL). However, little is known about ...

LAMP-5 is an essential inflammatory-signaling regulator and novel immunotherapy target ...
https://doi.org/10.3324/haematol.2020.257451
Haematologica Gracia-Maldonado G, Clark J et. al.

Apr 29th, 2021 - Although great advances have been made in understanding the pathobiology of MLL-rearranged (MLL-r) leukemias, therapies for this leukemia have remained limited, and clinical outcomes remain bleak. To identify novel targets for immunotherapy treatm...

Expression of YY1 in pro-B and T phenotypes correlation with poor survival in pediatric...
https://doi.org/10.1080/08880018.2020.1871139
Pediatric Hematology and Oncology; Antonio-Andres G, Jiménez-Hernandez E et. al.

Apr 26th, 2021 - Acute lymphoblastic leukemia (ALL) is the most common pediatric cancer, constituting 80% of all acute leukemias in minors. Despite the increase in the success of therapies, disease-free survival is over 80% in most cases. For the remaining 20% of ...

Interstitial Deletions Generating Fusion Genes.
https://doi.org/10.21873/cgp.20251
Cancer Genomics & Proteomics; Panagopoulos I, Heim S

Apr 24th, 2021 - A fusion gene is the physical juxtaposition of two different genes resulting in a structure consisting of the head of one gene and the tail of the other. Gene fusion is often a primary neoplasia-inducing event in leukemias, lymphomas, solid malign...

Second Malignancies after Radiation Therapy: Update on Pathogenesis and Cross-sectional...
https://doi.org/10.1148/rg.2021200171
Radiographics : a Review Publication of the Radiological ... Khanna L, Prasad SR et. al.

Apr 23rd, 2021 - A wide spectrum of second cancers occur as late complications of radiation therapy (RT) used to treat various malignancies. In addition to the type and dose of radiation, lifestyle, environmental, and genetic factors are important to the developme...

see more →

Guidelines  19 results

Acute Myeloid Leukemia - AML | ARUPConsult Lab Test Selection
https://arupconsult.com/content/acute-myeloid-leukemia

Jun 30th, 2019 - Acute myeloid leukemias (AMLs) are a heterogeneous group of disorders characterized by the clonal expansion of myeloid blasts (eg, undifferentiated myeloid precursors) in the peripheral blood, bone marrow, and/or other tissues, which results in im...

Acute Myeloid Leukemia, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology
https://jnccn.org/view/journals/jnccn/17/6/article-p721.xml
Journal of the National Comprehensive Cancer Network;

Jun 14th, 2019 - Acute myeloid leukemia (AML) is the most common form of acute leukemia among adults and accounts for the largest number of annual deaths due to leukemias in the United States. Recent advances have resulted in an expansion of treatment options for ...

23rd Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma
https://www.gotoper.com/conferences/hem/meetings/23rd-international-congress-on-hematologic-malignancies-focus-on-leukemias-lymphomas-and-myeloma

Feb 27th, 2019 - Now in its 23rd year, the annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma provides practitioners who manage hematologic malignancies the practical tools to translate emerging data into the bes...

Hematology Quality Metrics
http://www.hematology.org/Clinicians/Guidelines-Quality/503.aspx
Allen, S.

Feb 20th, 2018 - These clinical performance measures are designed for individual quality improvement. Some of the measures may also be appropriate for accountability if appropriate sample sizes and implementation rules are achieved.

see more →

Drugs  39 results see all →

Clinicaltrials.gov  4,723 results

Patterns of surveillance for late effects of BCR-ABL tyrosine kinase inhibitors in surv...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082962
BMC Cancer; Smith SM, Sabnis HS et. al.

Apr 30th, 2021 - Targeted anticancer therapies such as BCR-ABL tyrosine kinase inhibitors (TKIs) have improved outcomes for chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph + ALL). However, little is known about ...

LAMP-5 is an essential inflammatory-signaling regulator and novel immunotherapy target ...
https://doi.org/10.3324/haematol.2020.257451
Haematologica Gracia-Maldonado G, Clark J et. al.

Apr 29th, 2021 - Although great advances have been made in understanding the pathobiology of MLL-rearranged (MLL-r) leukemias, therapies for this leukemia have remained limited, and clinical outcomes remain bleak. To identify novel targets for immunotherapy treatm...

Expression of YY1 in pro-B and T phenotypes correlation with poor survival in pediatric...
https://doi.org/10.1080/08880018.2020.1871139
Pediatric Hematology and Oncology; Antonio-Andres G, Jiménez-Hernandez E et. al.

Apr 26th, 2021 - Acute lymphoblastic leukemia (ALL) is the most common pediatric cancer, constituting 80% of all acute leukemias in minors. Despite the increase in the success of therapies, disease-free survival is over 80% in most cases. For the remaining 20% of ...

Interstitial Deletions Generating Fusion Genes.
https://doi.org/10.21873/cgp.20251
Cancer Genomics & Proteomics; Panagopoulos I, Heim S

Apr 24th, 2021 - A fusion gene is the physical juxtaposition of two different genes resulting in a structure consisting of the head of one gene and the tail of the other. Gene fusion is often a primary neoplasia-inducing event in leukemias, lymphomas, solid malign...

Second Malignancies after Radiation Therapy: Update on Pathogenesis and Cross-sectional...
https://doi.org/10.1148/rg.2021200171
Radiographics : a Review Publication of the Radiological ... Khanna L, Prasad SR et. al.

Apr 23rd, 2021 - A wide spectrum of second cancers occur as late complications of radiation therapy (RT) used to treat various malignancies. In addition to the type and dose of radiation, lifestyle, environmental, and genetic factors are important to the developme...

see more →

News  245 results

The Next 'Big Thing' for Blood Cancers Featured at ASH 2019
https://www.staging.medscape.com/viewarticle/921942

Dec 6th, 2019 - The prospect of an "off-the-shelf" product, rather than one that needs to be grown individually for each patient, is a "very exciting" proposition, say experts discussing new data that will be presented at the forthcoming American Society of Hemat...

The Next 'Big Thing' for Blood Cancers Featured at ASH 2019
https://www.medscape.com/viewarticle/921942

Dec 6th, 2019 - The prospect of an "off-the-shelf" product, rather than one that needs to be grown individually for each patient, is a "very exciting" proposition, say experts discussing new data that will be presented at the forthcoming American Society of Hemat...

Federal Health Care Cancer Data Trends 2019
https://www.mdedge.com/fedprac/article/209596/federal-health-care-cancer-data-trends-2019?channel=167

Oct 7th, 2019 - Click here to access Federal Health Care Cancer Data Trends 2019 Table of Contents Introduction Cancer in the VA: The Big Picture Hepatocellular Carcinoma Prostate Cancer Multiple Myeloma Lung Cancer in the VA at a National Level Lung Cancer – Reg.

Leukemia Federal Health Care Data Trends
https://www.mdedge.com/fedprac/avaho/article/208837/oncology/leukemia-federal-health-care-data-trends?channel=263
Joao L. Ascensao, MD, PhD, FACP

Sep 25th, 2019 - (function(n){var r="_ion_ionizer",t=n. getElementsByTagName("script"),i;t=t[t.

see more →

Patient Education  1 results see all →